Livzon Pharma of Zuhai led a $26 million Series B funding of Cynvenio Biosystems, a Los Angeles diagnostics company; DelMar Pharma, a Canada-California drug company, will raise $8 million to develop its China-sourced cancer drug; J&J and WuXi AppTec will form a collaborative China life science incubator; China invalidated one of Gilead Sciences' patents for Sovaldi, its expensive new hepatitis C treatment; UCB of Belgium reported positive data from a China trial of its transdermal patch product for Parkinson's; Fosun Pharma said it would use M&A to increase ex-China revenues to 40% of sales; and Pfizer began construction of a $95 million production facility in Suzhou for consumer health products.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
